Anacor Pharma (ANAC) reports partner GlaxoSmithKline (GSK) has voluntarily paused enrollment of ongoing GSK '052 Phase 1, 2 Clinical Trials
Up)
Anacor Pharma (Nasdaq: ANAC) reports partner GlaxoSmithKline (NYSE: GSK) has voluntarily paused enrollment of ongoing GSK '052 Phase 1, 2 Clinical Trials
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Auxilium (AUXL) Files Suit Against Watson (WPI) Over Testim 1% Gel
- Alnylam and PBL Sign License Agreement for Baulcombe & Hamilton RNAi Patent
- Mylan (MYL) Launches Generic Bonviva Tabs (RHHBY) in Italy & the U.K.
Create E-mail Alert Related Categories
Corporate News, FDA, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
